Chinese Journal of Pharmacovigilance ›› 2018, Vol. 15 ›› Issue (11): 696-697.
• Orginal Article • Previous Articles Next Articles
FAN Baoxia, ZHANG Huajin, LI Na*
Received:2019-01-09
Revised:2019-01-09
Online:2018-11-20
Published:2019-01-09
CLC Number:
FAN Baoxia, ZHANG Huajin, LI Na. One Case of Visual Disturbances Induced by Oxaliplatin for Injection[J]. Chinese Journal of Pharmacovigilance, 2018, 15(11): 696-697.
| [1] Mesquida M, Sanchez-Dalmau B, Ortiz-Perez S, et al.Oxaliplatin-related ocular toxicity[J]. Case Rep Oncol, 2010, 3(3):423-427. [2] O'Dea D, Handy C M, Wexler A. Ocular changes with oxaliplatin[J]. Clin J Oncol Nurs, 2006, 10(2):227-229. [3] Jansman F G, Sleijfer D T, de Graaf J C, et al. Management of chemotherapy-induced adverse effects in the treatment of colorectal cancer[J]. Drug Saf, 2001, 24(5):353-367. [4] 王登山, 朱敏. 胃复安致双目失明一例[J]. 临床内科杂志, 1991,8(1):12. [5] 沈建飞, 吴嫣, 盛一梁. 注射用奥沙利铂致过敏性休克1例[J].中国药物警戒, 2016,13(8):509-512. [6] Leonard G D, Wright M A, Quinn M G, et al.Survey of oxaliplatin-associated neurotoxicity using an interview-based question- naire in patients with metastatic colorectal cancer[J].BMC Cancer, 2005,16,(5):116. [7] Cersosimo R J.Oxaliplatin-associated neuropathy: a review[J].Ann Pharmacother, 2005, 39(1):128-135. [8] Grothey A.Oxaliplatin-safety profile: neurotoxicity[J]. Semin Oncol, 2003, 30(4 sl 15):5-13. [9] 王丽君, 黎治平, 郑智, 等.奥沙利铂神经毒性的治疗研究进展[J].肿瘤药学, 2013, 3(6):409-413. [10] Pulvers J N, Marx G.Factors associated with the development and severity of oxaliplatin-induced peripheral neuropathy: a systematic review[J]. Asia Pac J Clin Oncol, 2017, 13(6):345-355. |
| [1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
| [2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
| [3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
| [4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
| [5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
| [6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
| [7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
| [8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
| [9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
| [10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
| [11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
| [12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
| [13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
| [14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
| [15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
